Veeva Systems Inc. is the leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 775 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices throughout North America, Europe, Asia, and Latin America. For more information, visit veeva.com.
Veeva SiteVault Free is a free 21 CFR Part 11 eRegulatory application that simplifies compliance and speeds study activation. SiteVault replaces paper regulatory binders and manual processes with capabilities such as electronic signatures, remote monitoring, certified copy workflows, and reporting. SiteVault is built on the proven clinical operations technology used by more than 200 sponsors, including 12 of the top 20 global biopharma companies. Learn more at sites.veeva.com and sign up today.
Veeva SiteVault Enterprise is a fully configurable eRegulatory system that reduces the administrative burden in clinical trials by simplifying the management of regulatory documents and processes across all studies. SiteVault is brought to you by Veeva, the leading provider of clinical operations technology to more than 200 sponsors and leading research organizations.
MyVeeva is a patient-centric portal to help clinical research sites conduct virtual visits and deliver a better patient experience. With capabilities for eSource, ePRO, eConsent, and patient adherence, My Veeva will make it easier for patients to participate in clinical trials. My Veeva is free for clinical research sites and will enable patients, doctors, and clinical research coordinators to collaborate remotely, reducing the need for in-person visits. You can read more here.
PLEASANTON, CA — Oct. 3, 2019 — Veeva Systems (NYSE:VEEV) today announced Veeva SiteVault Free, a free eRegulatory solution built specifically for clinical research sites. Veeva SiteVault allows sites to more effectively manage regulatory documents and trial processes to speed study activation and improve investigator site file management. Now all sites can have access to a modern cloud solution to streamline trial activities and accelerate clinical research. More »
Veeva Systems announced MyVeeva, a new application for clinical research sites. With capabilities for virtual visits, patient adherence, ePRO, eConsent, eSource and an easy to use patient portal, MyVeeva will make it easier for clinical research sites to deliver a patient-centric and paperless clinical trial experience for patients and sponsors. MyVeeva is free for clinical research sites and integrates seamlessly with Veeva SiteVault. More »
Looking to implement remote monitoring at your clinical research site? Download this step-by-step guide to get started. You will receive SOP for remote monitoring, templates for study-specific source plans, regulations, resources, and best practices. More »
With many monitors now restricted from travel, sites and sponsors are reassessing ways to share information and collaborate virtually. As a result, sites and sponsors are exploring the potential of remote monitoring solutions. Explore best practices for getting started with remote monitoring > More »
To increase efficiency, improve access to information, and reduce operating costs, Alliance Clinical Research turned to eRegulatory software. Discover how they found more time for patient recruitment and care and strengthened relationship with sponsors. More »
Researching eRegulatory management software for your clinical research site? Download this guide to review the most important features and questions to ask during your evaluation. Access the buyer's guide to learn: Industry drivers for change Core features of eRegulatory software 15 questions to ask vendors during your evaluation More »
In a recent webinar, “Less Red-Tape, More Research: Reduce the Administrative Burden in Clinical Research,” Megan Blair, the associate director of regulatory affairs at Penn Medicine, discusses their approach for evaluating and adopting new technologies within the organization. She offers tips for sites considering the use of technology to reduce the administrative burden in clinical research. More »
Veeva SiteVault helps reduce the administrative burden of managing regulatory documentation and trial information to accelerate clinical research. Learn morea about SiteVault and the differences between SiteVault Free and SiteVault Enterprise. More »
Veeva eConsent Product Demo August 2, 2021 10:10am
Veeva eConsent is a new way of thinking about the consenting process for patients – and it’s free for sites. Watch an in-depth demo to...
View this post
Five Considerations for Sites When Selecting an eConsent Solution July 21, 2021 2:51pm
If you need to streamline informed consent for your next study, here are five key considerations to help select the right eConsent solution. Read full...
View this post
Comprehensive Cancer Centers of Nevada Goes Beyond Paper Binders to Enable Remote Site Monitoring July 7, 2021 12:45pm
Explore how Comprehensive Cancer Centers of Nevada (CCCN) modernized its regulatory documentation practices to enable remote site monitoring and improve efficiencies. Challenges Manual processes were...
View this post
Accelerating Research Site Operations: Lessons from the University of Louisville June 25, 2021 1:58pm
Four lessons learned from changes made by research sites during the pandemic to drive long-term success. Read the full article
View this post
Research Site Technology Strategy Template June 7, 2021 2:15pm
Technology is revolutionizing clinical trials by streamlining study conduct – but, adding site-owned technology without a strategy can end up creating more complex challenges like...
View this post
Shifting from Paper to Digital Patient Consent June 7, 2021 1:39pm
Crofoot Research Center discusses how offering a digital patient experience in trials enables the site to provide better patient care. Read the full article
View this post
VP of Strategy, Site Solutions
Veeva Systems, Inc.
Tennessee
Join the discussion in our LinkedIn Group